Signature of a global and exclusive licence agreement for the exploitation of OphtAI

30 January 2019
  • Share this post :
Licence exclusive globale OphtAI

The signature of the agreement concludes succesffully a fantastic public private partnership. Indeed, OphtAI is an artificial intelligence algorithm, resulting from 3 years of collaboration between researchers, clinicians and industrials.

Evolucare, which was already providing to AP-HP the tele-ophtalmology platform they used between 2004 and 2017 for the screening of diabetic retinopathy, is adding to its portfolio an Artifical Intelligence algorithm with the ambition to revolutionize the screening of this disease. To cope with the insufficient number of ophthalmologists and the growing number of diabetics in the world, OphtAI offers to automate the detection of lesions on the retina and the evaluation of the grade of the disease.

The signature of this global and exclusive agreement also sets the foundation for a promising future. OphtAI is being CE marked as a Medical Device and will thus be put in the market shortly. The to-be-created Joint-Venture between Evolucare and ADCIS, a company specialized in image treatment and the longstanding partner of the project, will be in charge of its commercial exploitation. This JV intends to pursue the development of other tools for the screening, diagnosis and follow up of diseases that can be detected through the retina.

To know more :
Innovation: AI at the service of diabetic retinopathy screening

Discover Evolucare

International strategy

Evolucare Labs

Our Expertise
5
Production
5
Interoperability
5
Projects & Deployment
5
Customer service
5
Quality & Safety
5
Cross functions
Our partners
Working at Evolucare
Sanitaire

Hospitals / Clinics

criticalcare-w

Critical Care

5

Surgical Process

5
Anesthesia
5
Intensive Care
Medico-social
Nursing Home
5

Disabled People

5
Elderly People
5
HR & Scheduling
5
Management
medicalimaging-w
Medical Imaging
5
RIS-PACS
5
Consoles
5
Sharing
5
Teleradiology
Ophtalmologie-IA

Ophthalmology

Sie werden auf die Website OPHTAI.COM der Evolucare-Gruppe weitergeleitet.
ophtai-group
You will be redirected to the OPHTAI.COM website of Evolucare Group.
ophtai-group
Vous allez être redirigé sur le site OPHTAI.COM du Groupe Evolucare.
ophtai-groupe

Evolucare entdecken

Internationale Strategie

Evolucare Labs

Unsere kompetenzen

5
Produktion
5
Interoperabilität
5
Projekte & Implementierung
5
Kundenservice
5
Qualität - Sicherheit
5
Querschnittsabteilungen

Partnernetzwerk

Arbeiten bei Evolucare

Découvrir Evolucare

Nos partenaires

Nos formations

Evolucare Labs

Expertises et métiers

5
Recherche et Développement
5
Interopérabilité
5
Projets et déploiement
5
Service client & support
5
Qualité et sécurité
5
Fonctions transverses

Recrutement

5
Travailler chez Evolucare
5
Nos offres sur Indeed
5
Nous retrouver sur WTTJ
Accédez à HappyTeams
Sanitaire

Krankenhause

criticalcare-w

Intensivpflege

5

Chirurgischen Prozesses

5
Anästhesieakte
5
Intensivstationen
Medico-social
Sozialer Pflegebereich
5

Behinderungen

5
Ältere Leute
5
Personalwesen
5
Verwaltung
medicalimaging-w
Medizinische Bildgebung
5
RIS-PACS
5
Bildschirm-Konsole
5
Verbreitung
5
Teleradiologie
Ophtalmologie-IA

Ophthalmologie

ESMS Numérique
Ségur de la santé
Sanitaire

SIH - DPI

Medico-social
Médico-Social
criticalcare-w

Soins critiques

medicalimaging-w
Imagerie médicale
hebergement
Hébergement HDS
Ophtalmologie-IA

Ophtalmologie